首页> The Journal of molecular diagnostics : JMD> EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with Hematuria.

EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with Hematuria.

导出原文传递

翻译打印收藏纠错

第一作者： Bo-Ram,Bang

第一单位： Promis Diagnostics Inc., Irvine, California.

作者： Bo-Ram,Bang ^[1] ; Jin,Zhong ^[2] ; Tae Jeong,Oh ^[3] ; Ji Yong,Lee ^[4] ; Yangyei,Seo ^[3] ; Min A,Woo ^[3] ; Jae Sung,Lim ^[4] ; Yong Gil,Na ^[4] ; Ki Hak,Song ^[4] ; Ju Hyun,Shin ^[4] ; Justin Junguek,Lee ^[1] ; Chan Su,Im ^[1] ; Seoyong,Kim ^[1] ; Safedin,Beqaj ^[1] ; Joseph D,Shirk ^[5] ; Katelyn W,Ke ^[2] ; John,Vallone ^[2] ; Sungwhan,An ^[6]

作者单位： Promis Diagnostics Inc., Irvine, California. ^[1] Pathology and Laboratory Medicine Service, VA Greater Los Angeles Medical Center, Los Angeles, California. ^[2] Genomictree, Inc., Daejeon, Republic of Korea. ^[3] Department of Urology, Chungnam National University College of Medicine, Daejeon, Republic of Korea. ^[4] Department of Urology, VA Greater Los Angeles Medical Center, Los Angeles, California; Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California. ^[5] Promis Diagnostics Inc., Irvine, California; Genomictree, Inc., Daejeon, Republic of Korea. Electronic address: sungwhan@genomictree.com. ^[6]